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Intracerebral haemorrhage is a devastating neurological disease with high mortality 
rate and poor prognosis. The most prominent manifestation of the disease are 
the movement disorders, but many patients also suffer from cognitive impair-
ment. Taking into account vulnerability of the neurons located within the hilus 
of the dentate gyrus (HDG) to many brain insults we decided to study the effect 
of experimentally induced intracerebral haematoma on density of neurons ex-
pressing NogoA protein in HDG. In addition, we studied how administration of 
valproic acid and minocycline, the two drugs generally believed to be neuropro-
tective agents, influences the density of these neurons. Our study revealed that 
4 weeks after intracerebral haematoma induction, minocycline and valproic acid 
treatment increased the densities of NogoA-ir neurons in the hilus of contralateral 
dentate gyrus once the data were compared to ipsilateral hemispheres within the 
same group. The analysis of contralateral hemisphere data, however, revealed 
increased densities of NogoA-positive neurons in haematoma and valproic acid 
treated animals when compared to contralateral hemispheres of control animals. 
The administration of minocycline was, however, able to alleviate this increase. 
These changes may influence the haematoma-induced reorganisation of neuronal 
circuitries in the dentate gyrus. (Folia Morphol 2014; 73, 3: 279–285)
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INTRODUCTION
Intracerebral haemorrhage, a type of acute stroke, 
is a devastating neurological disease characterised with 
high mortality rate and poor prognosis. At present the-
re are no effective drug therapies available. Therefore 
many human and experimental model studies focus on 
developing the treatment that would at least alleviate 
the brain damage or its consequences. Although the 
most prominent manifestation of the disease are the 
movement disorders, many patients also suffer from 
cognitive impairment. Deficits in hippocampus-depen-
dent learning and memory processes have also been 
described both, in human and experimental models of 
the disease [4, 11, 13, 24]. 
In our study we focused on dentate gyrus. The major 
input to the dentate gyrus is provided by the entorhinal 
cortex via perforant pathway [1, 37], while dentate gyrus 
predominantly targets its projections to the CA3 field 
of hippocampus proper. Taking into account that the 
entorhinal cortex is the main source of sensory informa-
280
Folia Morphol., 2014, Vol. 73, No. 3
tion that hippocampal formation utilizes to carry out its 
function, the dentate gyrus is considered to be the first 
step in processing of information leading to memory 
formation. The dentate gyrus is made of 3 cellular layers: 
relatively cell-free molecular layer, principal cell layer 
called granule cell layer and innermost polymorphic 
cell layer in which mossy cells are the most prominent 
[2, 14]. The polymorphic cell layer is often referred as 
hilus of the dentate gyrus (HDG) [1, 37]. 
NogoA is a transmembrane protein of about 1200 
amino acids [5, 10] and is one of the most potent neurite 
growth inhibitors in central nervous system (CNS) myelin 
and tissue [39]. NogoA is mainly expressed by oligoden-
drocytes in the adult CNS, but several brain regions con-
taining NogoA-expressing neurons were also identified 
[12]. It is generally believed that NogoA expression in 
adult brain is characteristic for plastic CNS regions like 
cortex, dorsal root ganglia and of course hippocampus 
[28, 30, 34]. In human, increased immunoreactivity of 
NogoA-positive hippocampal neurons was observed 
in Alzheimer disease [9] and temporal lobe epilepsy 
[3]. The increase was also present in the experimental 
models of brain diseases including epilepsy [28, 41] or 
brain injury [26, 28, 30].
Taking into account the presence of NogoA expres-
sing neurons in HDG as well as vulnerability of the 
hilar region neurons, as demonstrated by studies on 
temporal lobe epilepsy or traumatic brain injury [19, 
37], we decided to study the effect of experimentally 
induced intracerebral haematoma on density of NogoA-
-expressing neurons in HDG. In addition, we checked 
how valproic acid and minocycline, the two drugs wi-
dely reported to reduce the damage in several models 
of brain injury, influence the density of these neurons. 
MATeRIAls AND MeThODs
Animal procedures
Twenty adult male Wistar rats (weighting 262–287 g) 
were housed individually in polycarbonate cages and 
had free access to water and food pellets. Temperature 
(21.1°C) and lighting (light on from 7:00 am–7:00 pm) 
regimens were maintained at constant level. 
The care and treatment of the rats conformed to 
the guidelines for laboratory animals established by the 
European Community Council Directive of 24 November 
1986 (86/609/EEC), and the Local Ethical Committee of 
the Medical University of Gdansk. All the rats were divi-
ded into 4 experimental groups: control (CON, n = 5), 
haematoma (HAEM, n = 5), haematoma and minocyc-
line (MINO, n = 5) and haematoma and valproic acid 
(VAL, n = 5) groups. The control group comprised of 
animals that underwent the same surgical procedure 
as rats that were subjected to intracerebral haema-
toma (described below) with the exception of blood 
injection. In the study we used the experimental model 
of intracerebral haemorrhage described previously by 
Karwacki et al. [15–17] where detailed description of 
anaesthetic and surgical procedures were presented. 
Here we provide brief description of the experimental 
procedures used. In all the groups, the animals were 
generally anaesthetised with intraperitoneal injections 
of a mixture of fentanyl (Fentanyl, Polfa-Warszawa, 
Poland) with a dose of 0.02 µg/kg and dehydrobenzpe-
ridol (Droperidol, G. Richter; Hungary) with a dose of 
0.75 µg/kg. Then intubation tube was inserted to the 
trachea and the animals were mechanically ventilated 
with the Small Animal Ventilator SAR 830/p (CWE, Inc. 
USA), using a mixture of air and Sevoflurane (Baxter, 
Deerfield, IL, USA). Than the femoral artery was ex-
posed and cannulated for blood sampling. Next, the 
animal was fixed in a stereotaxic frame and the skull 
was exposed. Then the whole was drilled in the skull in 
order to introduce the capillary into the left striatum. 
The stereotaxic coordinates for capillary placement 
(3.3 mm posteriorly, 6.0 mm left and 9.0 mm ventrally 
to the bregma) were based on rat brain atlas of Paxinos 
and Watson [32]. After introducing the capillary into 
the brain the 150 µL of autologous arterial blood was 
injected for 10 min. The capillary was left in place for 
another 5 min, than it was slowly withdrawn. Two 
rats (1 in HAEM and 1 in VAL groups) died within the 
first 24-h after haematoma induction; therefore the 
final analysis in these two experimental groups was 
performed on 4 animals. 
Medication
Two hours after completing the surgery procedures 
rats assign to MINO and VAL groups received twice per 
day (for 7 consecutive days) intraperitoneal injections 
of minocycline (M9511, Sigma-Aldrich GmbH, Germa-
ny; 45 mg/kg) or valproic acid (P4543, Sigma-Aldrich 
GmbH, Germany; 200 mg/kg following loading dose 
of 400 mg/kg) dissolved in 2 mL of 0.09% saline (Pol- 
pharma, Poland). The CON and HAEM animals received 
2 mL of saline injections only.
Tissue collection and preparation
Four weeks after haematoma induction rats were 
deeply anaesthetised (Thiopental, 100 mg/kg, i.p.) and 
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initially flushed transcardially with the 0.9% sodium 
chloride and then perfused with 4% paraformaldehyde 
in the 0.1 M phosphate buffer at 4°C. Subsequently, the 
brains were removed, post-fixed for 2 h in the perfusing 
solution and then cryoprotected by immersion in 30% 
sucrose at 4°C until they sunk. Next, the brains were cut 
into 40 µm coronal sections cryostat (Jung CM1800, 
Leica, Germany) and stored in tissue collecting solution 
(30% ethylene glycol, 25% glycerol in 0.05 M sodium 
phosphate buffer) at –20°C until further processing.
Nissl staining and immunohistochemistry
To assess the cytoarchitectonic boundaries of the 
dentate gyrus one series of sections was stained with 
10% cresyl violet. The remaining series of sections were 
double-labelled with standard immunohistochemical 
protocols using antibodies against the NogoA and neu-
ronal marker NeuN. Briefly, after 3 washings (15 min 
each) in phosphate buffered saline, sections were blo-
cked in 5% normal goat serum and 0.3% Triton X-100 
for 2.5 h at room temperature. For double staining, 
sections were first incubated with a cocktail of primary 
containing 1:200 solution of a rabbit polyclonal NogoA 
antibody (sc-25660, Santa Cruz Biotechnology, Inc., 
Dallas, TX, USA) and 1:300 solution mouse monoclonal 
NeuN antibody (MAB377, Millipore Corporation, Bille-
rica, MA, USA) for 3 days at room temperature. Then 
the sections were washed 3 times for 15 min in 0.01 M 
PBS and incubated for 2.5 h at room temperature with 
the secondary antibodies cocktail containing 1:600 
goat anti-rabbit conjugated with Cy3 (#111-165-144, 
Jacksom ImmunoResearch Laboratories, West Grove, 
PA, USA) and 1:150 goat anti-mouse conjugated with 
Alexa Fluor 488 (A-11001, Molecular Probes, Eugene, 
OR, USA). Finally, the sections were washed, mounted 
on slides and coverslipped with Kaiser’s Glyceringe-
latine (#A12083, Merck, Germany). Specificity of the 
immunostaining was checked by omitting either the 
primary or secondary antibodies which resulted in total 
disappearance of the staining. 
Quantitative and statistical analysis
The CAST-Grid (Olympus, Denmark) image analysis 
system (LaserPix v. 4.0, BioRad, UK) and a 40 objective 
lens were employed to assess the number of NogoA-
-positive cells in the hilus of dentate gyrus in both 
hemispheres. The HDG was outlined and computer-
-aided estimation was used to estimate the number 
of NogoA-ir cell profiles per unit area for each investi-
gated hippocampal structure. The grid size was either 
4067 µm2. At least one-half of the area of a given 
section was analysed; the first test area was chosen 
randomly and the remaining ones were selected by 
systematic random sampling. Statistical analysis was 
performed using KyPlot (v. 2.0) software. To compa-
re the densities of NogoA-ir neurons between ipsi- 
and contralateral hemispheres in each experimental 
group, Mann-Whitney U Test was applied. To compare 
the data from ipsi- or contralateral hemispheres to 
controls and between groups Steel and Steel-Dwass 
Tests were used, respectively. Significant values were 
set at p < 0.05. 
ResUlTs
Double labelled immunostaining revealed that 
within the HDG nearly all NogoA-ir cells were also 
NeuN-positive, therefore we considered them neu-
rons (Fig. 1). The remaining NogoA-positive cells 
were presumably oligdendrocytes because they did 
not express typical neuronal morphology as well as 
Figure 1. Confocal microphotograph presenting NeuN-ir nuclei, NogoA-positive cytoplasm and merged picture of neurons located in the hilus 
of dentate gyrus contralateral to intracerebral haematoma in valproic acid-treated rat. The pictures were taken under magnification × 40.
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microglial (Ox6, OX42) or astroglial markers (GFAP) 
(unpublished data).
Comparisons of the densities of NogoA-ir neu-
rons in HDG between hemispheres ipsi- and contra-
lateral to the haematoma revealed no difference in 
control and haematoma groups. On the other hand 
the densities were significantly increased in contra-
lateral hemispheres, when compared to ipsilateral 
ones, in minocycline and valproic acid treated animals 
(p < 0.05, Mann-Whitney U test) (Fig. 2).
Next we compared the densities of NogoA-ir 
neurons in ipsilateral hemispheres to control groups 
and among all experimental groups. The analysis re-
vealed no differences between them (Fig. 2). Similar 
analysis performed for contralateral hemispheres, 
however, disclosed the higher densities of NogoA 
cells in haematoma and valproic acid-treated ani-
mals when compared to controls (p < 0.05, Steel 
test) (Fig. 2). 
DIsCUssION
Our study revealed that 4 weeks after intracerebral 
haematoma induction, minocycline and valproic acid 
treatment increased the densities of NogoA-ir neu-
rons in the hilus of contralateral dentate gyrus once 
the data were compared to ipsilateral hemispheres 
within the same group. Interestingly, the analysis of 
contralateral hemisphere data from different exper-
imental groups disclosed increase in densities of 
NogoA-positive neurons in haematoma and valproic 
acid treated animals when compared to contralateral 
hemispheres of control animals. No such effect was 
observed in minocycline-treated rats.
NogoA was first identified as a myelin-associated 
protein expressed in mature oligodendrocytes, but 
recently its presence has been demonstrated in se-
veral CNS regions, both in developing and mature 
neurons. During development, Nogo-A influences 
migration and neurite outgrowth of cortical neurons 
[31], conducts corticospinal axons growing along the 
spinal cord, and regulates the progressive restriction 
of plasticity [8, 27]. Few data from studies on adult 
brains have been published suggesting that NogoA 
constitutively controls the architecture of neurons 
in the intact hippocampus (mainly via a receptor 
mediated mechanisms) [33, 44]. Moreover, electro- 
physiological studies revealed that NogoA or NogoA 
receptor neutralisation significantly increased the 
long term potentiation in hippocampal neurons [7]. 
It may indicate unique role of NogoA signalling in 
restricting physiological synaptic plasticity. Therefore 
NogoA may serve as important negative regulator of 
functional and structural plasticity in mature neuronal 
networks in the adult hippocampus. Majority of the 
NogoA studies, however, focused on its crucial role in 
preventing repair processes in different CNS injuries 
and diseases (for review see [12, 34]). For example, 
in spinal cord lesion and ischaemic stroke models 
application of various NogoA antibodies or reagents 
blocking Nogo receptor NgR1 resulted in long-range 
axons regeneration and increased compensatory gro-
wth of intact fibres or at least significantly improved 
Figure 2. The densities of NogoA-ir neurons (± standard deviation) in the hilus of dentate gyrus of ipsi- and contralateral hemispheres 
4 weeks after induction of intracerebral haematoma in all experimental groups. Statistical significances marked with *p < 0.05 (Mann- 
-Whitney U test, Steel test); MINO — haematoma and minocycline group; VAL — haematoma and valproic acid group.
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functional recovery [34]. The concept of therapeutic 
antibody administration has been tested in clinical 
trials in para- and tetraplegic patients as well as in 
amyotrophic lateral sclerosis (due to the fact that No-
goA is ectopically expressed in neuromuscular junction 
as an early sign of the disease) [34]. On the other hand, 
in the wild type mice with NogoA blockage (by antibo-
dies) or in NogoA knock-out mice subjected to middle 
cerebral artery occlusion [20], observed decreased 
neuronal survival when compared to control groups. 
In addition, NogoA delta 20 transfection in cortical 
neurons protected the cells from oxidative stress in 
vitro [29]. Based on that one can believe that at NogoA 
expressed in neurons might also act as a neuroprotecti-
ve agent. In our study however, we observed increase in 
density of NogoA neurons in contralateral HDG of rats 
subjected to intracerebral haematoma. Therefore we 
rather believe that this increase is related to negative 
consequences of brain insult.
Valproic acid and minocycline has been considered 
a neuroprotective agents in several models of brain 
injuries and diseases [18, 23, 35, 43]. Neuroprotective 
effect of minocycline may be attributable to its antia-
poptotic, antioxidative and anti-inflammatory actions 
[18, 22]. In the experimental models of intracerebral 
haemorrhage models minocycline was shown to in-
hibit some inflammatory-related genes [42] as well 
as microglial/macrophage activation in peri-infarct 
region [43]. Study of Xue et al. [43] demonstrated that 
minocycline also alleviated neuronal cell death and 
improve behavioural recovery. On the other hand, no 
reduction of infarct volume or functional benefit was 
observed by Szymanska et al. [40]. Our analysis reve-
aled that administration of minocycline, started 2 h 
after induction of intracerebral haematoma, is able 
to prevent the increase of NogoA-ir in HDG neurons 
in contralateral hemisphere. 
Existing data on mouse model of intracerebral 
haemorrhage (induced by collagenase injections) sug-
gests that the administration of valproic acid inhibits 
haematoma expansion, perihaematomal cell death, 
caspase activation and inflammatory cell infiltration 
which results in behavioural improvement tested 
4 weeks later [38]. Similar effects (on infarct volume, 
inflammation or behavioural outcome) were observed 
in murine models of ischaemic stroke [21, 36] or 
traumatic brain injury [6]. It, however, looks like that 
beneficial effects observed the haematoma lodge 
cannot be observed in the HDG because in the con-
tralateral hemisphere the density of NogoA-positive 
neurons was higher than in sham-operated controls 
and similar increase was observed in rats with induced 
haematoma that did not received any drug treatment. 
Therefore positive effects of valproate acid treatment 
may be observed in brain region affected directly 
by the insult but not necessarily in the structures in 
which neurodegeneration develops as a consequence 
of primary insult. In addition, we always have to take 
into consideration that different experimental models 
used, time window between the insult and beginning 
of drug treatment as well as drug administration 
schemes may significantly influence obtained results. 
The other thing, that has to be discussed is the 
presence of the changes in the dentate gyrus con-
tralateral to the haematoma. The presence of strong 
commissural/association projection to corresponding 
contralateral dentate gyrus (including hilus) has been 
well characterised feature of HDG neurons [2, 37]. Via 
this projection pathological processes in the ipsilateral 
hemisphere may affect the contralateral side later on. 
For example, following kainate injection into CA3 sec-
tor of hippocampus different subpopulations of cells 
degenerated at different times in contralateral hilum 
or CA1 and CA3 sectors of hippocampus [25]. But in 
this study the “primary” injury was applied directly 
to hippocampus. Once the injury site was located 
outside the hippocampus more time was needed to 
observe changes in hippocampus ipsilateral to injury 
site. For example, Takeda et al. [41] used amygdala 
kindling model of temporal lobe epilepsy. They ob-
served that Nogo-A expression in the ipsilateral CA2 
and CA3 sectors of hippocampus gradually increased 
with the development of kindling, but no increase 
was observed in the contralateral hippocampus as 
the rats advanced to stage 5 of amygdala kindled 
seizures. The time the animals reached stage 5 seizu-
res differed between animals, but it did not exceed 
10 days which may explain no changes observed in 
contralateral side. In the fluid percussion model of 
traumatic brain injury applied to frontoparietal cor-
tex, numerous NogoA-ir neurons were observed in 
the hilus of the dentate gyrus of sham-injured rats. 
These neurons in the ipsilateral HDG were found to 
be selectively vulnerable to injury and their number 
was decreased 7 days after injury [26]. Unfortunately, 
analysis of contralateral hippocampus was performed 
in this study. The analysis of both, ipsi- and contra-
lateral sides, were made by Meier et al. [28]. In their 
study they evaluated the level of NogoA mRNA after 
deafferentation of hippocampus by electrocoaglu-
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lation of entorhinal cortex. In the HDG of ipsi- and 
contralateral hippocampi they observe more than 
30-fold increase during early phase of lesioning, but 
the level was decreased below control level at 15–21 
days post injury. In their study NogoA mRNA was also 
upregulated 5 days after intraperitoneal injections 
of kainic acid. On the other hand, Mignorance et al. 
[30] observed opposite effects using similar lesions. 
Twenty four hours after kainite injections Nogo mRNA 
was strongly downregulated and only slight tran-
sient upregulation of Nogo mRNA was noticed in 
the ipsilateral hippocampus (including dentate gyrus) 
3 days after entorhinal cortex lesions. No changes were 
observed contralaterally. Differences in the in situ 
hybridisation probes as well as NogoA protein domain 
recognised by the antibodies employed in these stu-
dies are likely to be responsible for such discrepancies. 
In our study, we found significant increase in densities 
of neurons expressing NogoA protein in the contrala-
teral HDG, but no changes were observed in ipsilateral 
hemispheres. It is, however, important to remember 
that our analysis was performed 4 weeks following 
intracerebral haematoma induced in striatum, so 
there is a strong possibility that at this time point 
changes could be limited to contralateral hemisphere 
only. In addition, different type of primary brain injury, 
antibodies used and quantification methods might 
have influenced the results. 
CONClUsIONs
The role of neuronal NogoA expression remains 
unclear. It was, however, implicated that this protein 
is highly expressed in brain regions strongly involved 
in neuronal plasticity and its level of expression is 
also influenced by pathological processes changing 
the reorganisation of neuronal circuitries. Taking into 
account that HDG neurons control the excitability of 
dentate gyrus granule cells, increased expression of 
NogoA in these neurons may suggest that intracere-
bral haematoma induces formation of new synaptic 
contacts or at least reorganisation of existing circui-
tries. The administration of minocycline that alleviates 
the increase may influence these processes. Whether 
these changes affect hippocampal-dependent cogni-
tive outcome requires further studies. 
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